Hangzhou Tigermed Consulting Co., Ltd（stock symbol: 300347） is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical trial services. Since inception in 2004, Tigermed has been committed to accelerating medical product development with costs efficiency and quality. Headquartered in Hangzhou, Tigermed operates 33 subsidiaries, 95 offices across China and 11 overseas offices in Hong Kong China, Taiwan China, USA, Switzerland, Korea, Australia, Japan, Malaysia, Singapore, India and Romania with over 4000 full time staffs. Tigermed has serviced more than 600 local and global clients in the conduct of over 1500 clinical trials. Tigermed is recognized as “The Innovative Clinical CRO” in China，owning to our involvement of over 160 innovative drugs.
Phone: 86-571-28887227
Fax: 86-571-88211196
E-mail: bd@tigermed.net
Web: https://www.tigermed.net
Add：Fl.15,Dongguan Plaza,No.618 Jiangnan, Avenue,Binjiang,District,Hangzhou,P.R.China,Code：310053
Fl.16, Huawen International Building,No.999 West Zhongshan Road,Changning District, Shanghai,P.R.China,Code：200051
Room 808,Union Mansion,No.20 Chaoyangmen Outer Street,Chaoyang District, Beijing,P.R.China,Code：100022
想要下载更多资料，请您添加微信了解详情！
微信号：csco2022
公众号：康安医药咨询
